4.7 Meeting Abstract

Use of Von-Hippel Lindau (VHL) mutation status to predict objective response to vascular endothelial growth factor (VEGF) - targeted therapy in metastatic renal cell carcinoma (RCC)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Sorafenib in advanced clear-cell renal-cell carcinoma

Bernard Escudier et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Medicine, General & Internal

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Robert J. Motzer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Review Oncology

The pathology of renal epithelial neoplasms

Victor E. Reuter

SEMINARS IN ONCOLOGY (2006)

Review Urology & Nephrology

2004 WHO classification of the renal tumors of the adults

A Lopez-Beltran et al.

EUROPEAN UROLOGY (2006)

Article Oncology

Molecular classification of papillary renal cell carcinoma

XMJ Yang et al.

CANCER RESEARCH (2005)

Article Urology & Nephrology

Expression of vascular endothelial growth factor protein in human renal cell carcinoma

J Jacobsen et al.

BJU INTERNATIONAL (2004)

Article Biochemistry & Molecular Biology

Overexpression of KIT in chromophobe renal cell carcinoma

K Yamazaki et al.

ONCOGENE (2003)

Article Oncology

New guidelines to evaluate the response to treatment in solid tumors

F Duffaud et al.

BULLETIN DU CANCER (2000)

Article Oncology

New guidelines to evaluate the response to treatment in solid Tumors

P Therasse et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)